产品详情
Targets
Target | Value |
---|---|
C-Raf-1(Y340D/Y341D) | IC50: 6.7nM |
B-Raf(V600E) | IC50: 13nM |
BRK | IC50: 130nM |
B-Raf | IC50: 160nM |
FRK | IC50: 1.3μM |
CSK | IC50: 1.5μM |
Src | IC50: 1.7μM |
FAK | IC50: 1.7μM |
FGFR | IC50: 1.9μM |
KDR | IC50: 2.3μM |
HGK | IC50: 2.8μM |
CSF-1R | IC50: 3.3μM |
AuroraA | IC50: 3.4μM |
In vitro (25°C) | DMSO | 81 mg/mL (195.73 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+50% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.17 mL | 120.83 mL | 241.66 mL |
0.5 mM | 4.83 mL | 24.17 mL | 48.33 mL |
1 mM | 2.42 mL | 12.08 mL | 24.17 mL |
5 mM | 0.48 mL | 2.42 mL | 4.83 mL |
*The above data is based on the productmolecular weight 413.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10002 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 413.8 |
Formula | C17H14ClF2N3O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 918505-84-7 |
Synonyms | PLX4720 |
SMILES | CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F |
产品标签
Product Questions
Product Questions
PLX4032 (Vemurafenib)
PLX4032(Vemurafenib)也称为RG7204,Vemurafenib,R7204,RO5185426。PLX4032是B-raf抑制剂,IC50为44 nM。
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。
Dabrafenib Mesylate
Dabrafenib Mesylate是一种新颖,有效和选择性的Raf激酶抑制剂,能够抑制野生型B-Raf,B-RafV600E和c-Raf的激酶活…
Balamapimod (MKI-833)
Balamapimod (MKI-833)是Ras/Raf/MEK抑制剂。